According to Latest Research, the global market for Knee Joint Pain Injection should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Knee Joint Pain Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Knee Joint Pain Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Corticosteroid Injections segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.
The global key manufacturers of Knee Joint Pain Injection include Chugai Pharmaceutical, Seikagaku Corporation, Teva Pharmaceutical Industries, Zimmer Biomet Holdings, Flexion Therapeutics, Dr. Reddy's Laboratories, Anika Therapeutics, Sanofi S.A and Pfizer, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Knee Joint Pain Injection. Report Highlights:
(1) Global Knee Joint Pain Injection market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2023 to 2030.
(2) Global Knee Joint Pain Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(3) China Knee Joint Pain Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(4) Global Knee Joint Pain Injection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Knee Joint Pain Injection segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Knee Joint Pain Injection, capacity, production and trends.
(7) Knee Joint Pain Injection industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Corticosteroid Injections
Hyaluronic Acid Injections
Platelet Rich Plasma Injections
Others
Market segment by application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Chugai Pharmaceutical
Seikagaku Corporation
Teva Pharmaceutical Industries
Zimmer Biomet Holdings
Flexion Therapeutics
Dr. Reddy's Laboratories
Anika Therapeutics
Sanofi S.A
Pfizer
Wright Medical Group N.V
Ferring Pharmaceuticals
Bioventus
1 Market Overview
1.1 Knee Joint Pain Injection Definition
1.2 Global Knee Joint Pain Injection Market Size and Forecast
1.2.1 By Revenue, Global Knee Joint Pain Injection Market Size, 2019-2030
1.2.2 By Sales Volume, Global Knee Joint Pain Injection Market Size, 2019-2030
1.2.3 Global Knee Joint Pain Injection Price Trend, 2019-2030
1.3 China Knee Joint Pain Injection Market Size and Forecast
1.3.1 By Revenue, China Knee Joint Pain Injection Market Size, 2019-2030
1.3.2 By Sales Volume, China Knee Joint Pain Injection Market Size, 2019-2030
1.3.3 China Knee Joint Pain Injection Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Knee Joint Pain Injection Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Knee Joint Pain Injection Share in Global Market, 2019-2030
1.4.3 Knee Joint Pain Injection Market Size: China VS Global, 2019-2030
1.5 Knee Joint Pain Injection Market Dynamics
1.5.1 Knee Joint Pain Injection Market Drivers
1.5.2 Knee Joint Pain Injection Market Restraints
1.5.3 Knee Joint Pain Injection Industry Trends
1.5.4 Knee Joint Pain Injection Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Knee Joint Pain Injection Revenue by Company, 2019-2023
2.2 Global Knee Joint Pain Injection Sales Volume by Company, 2019-2023
2.3 Global Knee Joint Pain Injection Price by Company, 2019-2023
2.4 Global Knee Joint Pain Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Knee Joint Pain Injection Concentration Ratio
2.6 Global Knee Joint Pain Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Knee Joint Pain Injection Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Knee Joint Pain Injection Revenue by Company, 2019-2023
3.2 China Knee Joint Pain Injection Sales Volume by Company, 2019-2023
3.3 China Knee Joint Pain Injection Knee Joint Pain Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Knee Joint Pain Injection Market, Sales Percentage of Local Players VS Foreign Players (2019-2023)
3.5 Chinese Local Players, Knee Joint Pain Injection Domestic VS Export
3.6 China Market, Knee Joint Pain Injection Import & Export
3.6.1 China Market, Knee Joint Pain Injection Import & Export, 2019-2030
3.6.2 China Knee Joint Pain Injection Import & Export Trends
3.6.3 Main Sources of China Knee Joint Pain Injection Import
3.6.4 Export Destination of China Knee Joint Pain Injection
4 Knee Joint Pain Injection Production by Region
4.1 Global Knee Joint Pain Injection Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Knee Joint Pain Injection Manufacturers
4.3 Global Major Manufacturers, Knee Joint Pain Injection Capacity Expansion and Future Plans
4.4 Global Knee Joint Pain Injection Capacity by Region
4.5 Global Knee Joint Pain Injection Production by Region
4.5.1 Global Knee Joint Pain Injection Production & Forecast by Region, 2019 VS 2023 VS 2030
4.5.2 Global Knee Joint Pain Injection Production by Region, 2019-2023
4.5.3 Global Knee Joint Pain Injection Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Knee Joint Pain Injection Industry Chain
5.2 Knee Joint Pain Injection Upstream Analysis
5.2.1 Knee Joint Pain Injection Core Raw Materials
5.2.2 Main Manufacturers of Knee Joint Pain Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Knee Joint Pain Injection Production Mode
5.6 Knee Joint Pain Injection Procurement Model
5.7 Knee Joint Pain Injection Industry Sales Model and Sales Channels
5.7.1 Knee Joint Pain Injection Sales Model
5.7.2 Knee Joint Pain Injection Typical Distributors
6 Sights by Type
6.1 Knee Joint Pain Injection Classification
6.1.1 Corticosteroid Injections
6.1.2 Hyaluronic Acid Injections
6.1.3 Platelet Rich Plasma Injections
6.1.4 Others
6.2 By Type, Global Knee Joint Pain Injection Market Size & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Knee Joint Pain Injection Revenue, 2019-2030
6.4 By Type, Global Knee Joint Pain Injection Sales Volume, 2019-2030
6.5 By Type, Global Knee Joint Pain Injection Price, 2019-2030
7 Sights by Application
7.1 Knee Joint Pain Injection Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global Knee Joint Pain Injection Market Size & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Knee Joint Pain Injection Revenue, 2019-2030
7.4 By Application, Global Knee Joint Pain Injection Sales Volume, 2019-2030
7.5 By Application, Global Knee Joint Pain Injection Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Knee Joint Pain Injection Market Size, 2019 VS 2023 VS 2030
8.2 By Region, Global Knee Joint Pain Injection Revenue, 2019-2030
8.3 By Region, Global Knee Joint Pain Injection Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Knee Joint Pain Injection Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Knee Joint Pain Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Knee Joint Pain Injection Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Knee Joint Pain Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Knee Joint Pain Injection Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Knee Joint Pain Injection Market Size Market Share
8.7 South America
8.7.1 South America Knee Joint Pain Injection Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Knee Joint Pain Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Knee Joint Pain Injection Market Size & CAGR,2019 VS 2023 VS 2030
9.2 By Country, Global Knee Joint Pain Injection Revenue, 2019-2030
9.3 By Country, Global Knee Joint Pain Injection Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Knee Joint Pain Injection Market Size, 2019-2030
9.4.2 By Company, U.S. Knee Joint Pain Injection Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Knee Joint Pain Injection Market Size, 2019-2030
9.5.2 By Company, Europe Knee Joint Pain Injection Sales Volume Market Share, 2023
9.5.3 By Type, Europe Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Knee Joint Pain Injection Market Size, 2019-2030
9.6.2 By Company, China Knee Joint Pain Injection Sales Volume Market Share, 2023
9.6.3 By Type, China Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Knee Joint Pain Injection Market Size, 2019-2030
9.7.2 By Company, Japan Knee Joint Pain Injection Sales Volume Market Share, 2023
9.7.3 By Type, Japan Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Knee Joint Pain Injection Market Size, 2019-2030
9.8.2 By Company, South Korea Knee Joint Pain Injection Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Knee Joint Pain Injection Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Knee Joint Pain Injection Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Knee Joint Pain Injection Market Size, 2019-2030
9.10.2 By Company, India Knee Joint Pain Injection Sales Volume Market Share, 2023
9.10.3 By Type, India Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Knee Joint Pain Injection Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Knee Joint Pain Injection Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Knee Joint Pain Injection Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Chugai Pharmaceutical
10.1.1 Chugai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.1.2 Chugai Pharmaceutical Knee Joint Pain Injection Models, Specifications and Application
10.1.3 Chugai Pharmaceutical Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.1.4 Chugai Pharmaceutical Company Profile and Main Business
10.1.5 Chugai Pharmaceutical Recent Developments
10.2 Seikagaku Corporation
10.2.1 Seikagaku Corporation Company Information, Head Office, Market Area and Industry Position
10.2.2 Seikagaku Corporation Knee Joint Pain Injection Models, Specifications and Application
10.2.3 Seikagaku Corporation Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.2.4 Seikagaku Corporation Company Profile and Main Business
10.2.5 Seikagaku Corporation Recent Developments
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
10.3.2 Teva Pharmaceutical Industries Knee Joint Pain Injection Models, Specifications and Application
10.3.3 Teva Pharmaceutical Industries Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.3.4 Teva Pharmaceutical Industries Company Profile and Main Business
10.3.5 Teva Pharmaceutical Industries Recent Developments
10.4 Zimmer Biomet Holdings
10.4.1 Zimmer Biomet Holdings Company Information, Head Office, Market Area and Industry Position
10.4.2 Zimmer Biomet Holdings Knee Joint Pain Injection Models, Specifications and Application
10.4.3 Zimmer Biomet Holdings Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.4.4 Zimmer Biomet Holdings Company Profile and Main Business
10.4.5 Zimmer Biomet Holdings Recent Developments
10.5 Flexion Therapeutics
10.5.1 Flexion Therapeutics Company Information, Head Office, Market Area and Industry Position
10.5.2 Flexion Therapeutics Knee Joint Pain Injection Models, Specifications and Application
10.5.3 Flexion Therapeutics Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.5.4 Flexion Therapeutics Company Profile and Main Business
10.5.5 Flexion Therapeutics Recent Developments
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area and Industry Position
10.6.2 Dr. Reddy's Laboratories Knee Joint Pain Injection Models, Specifications and Application
10.6.3 Dr. Reddy's Laboratories Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.6.4 Dr. Reddy's Laboratories Company Profile and Main Business
10.6.5 Dr. Reddy's Laboratories Recent Developments
10.7 Anika Therapeutics
10.7.1 Anika Therapeutics Company Information, Head Office, Market Area and Industry Position
10.7.2 Anika Therapeutics Knee Joint Pain Injection Models, Specifications and Application
10.7.3 Anika Therapeutics Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.7.4 Anika Therapeutics Company Profile and Main Business
10.7.5 Anika Therapeutics Recent Developments
10.8 Sanofi S.A
10.8.1 Sanofi S.A Company Information, Head Office, Market Area and Industry Position
10.8.2 Sanofi S.A Knee Joint Pain Injection Models, Specifications and Application
10.8.3 Sanofi S.A Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.8.4 Sanofi S.A Company Profile and Main Business
10.8.5 Sanofi S.A Recent Developments
10.9 Pfizer
10.9.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.9.2 Pfizer Knee Joint Pain Injection Models, Specifications and Application
10.9.3 Pfizer Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.9.4 Pfizer Company Profile and Main Business
10.9.5 Pfizer Recent Developments
10.10 Wright Medical Group N.V
10.10.1 Wright Medical Group N.V Company Information, Head Office, Market Area and Industry Position
10.10.2 Wright Medical Group N.V Knee Joint Pain Injection Models, Specifications and Application
10.10.3 Wright Medical Group N.V Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.10.4 Wright Medical Group N.V Company Profile and Main Business
10.10.5 Wright Medical Group N.V Recent Developments
10.11 Ferring Pharmaceuticals
10.11.1 Ferring Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.11.2 Ferring Pharmaceuticals Knee Joint Pain Injection Models, Specifications and Application
10.11.3 Ferring Pharmaceuticals Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.11.4 Ferring Pharmaceuticals Company Profile and Main Business
10.11.5 Ferring Pharmaceuticals Recent Developments
10.12 Bioventus
10.12.1 Bioventus Company Information, Head Office, Market Area and Industry Position
10.12.2 Bioventus Knee Joint Pain Injection Models, Specifications and Application
10.12.3 Bioventus Knee Joint Pain Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.12.4 Bioventus Company Profile and Main Business
10.12.5 Bioventus Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Knee Joint Pain Injection Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Knee Joint Pain Injection Market Restraints
Table 3. Knee Joint Pain Injection Market Trends
Table 4. Knee Joint Pain Injection Industry Policy
Table 5. Global Knee Joint Pain Injection Revenue by Company, 2019-2023, US$ million
Table 6. Global Knee Joint Pain Injection Revenue Market Share by Company, 2019-2023
Table 7. Global Knee Joint Pain Injection Sales Volume by Company, 2019-2023, (K Units)
Table 8. Global Knee Joint Pain Injection Sales Volume Market Share by Company, 2019-2023
Table 9. Global Knee Joint Pain Injection Price by Company, 2019-2023, (US$/Unit)
Table 10. Global Knee Joint Pain Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Knee Joint Pain Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Knee Joint Pain Injection Manufacturers Product Type
Table 13. China Knee Joint Pain Injection Revenue by Company, 2019-2023, US$ million
Table 14. China Knee Joint Pain Injection Revenue Market Share by Company, 2019-2023
Table 15. China Knee Joint Pain Injection Sales Volume by Company, 2019-2023, (K Units)
Table 16. China Knee Joint Pain Injection Sales Volume Market Share by Company, 2019-2023
Table 17. China Market, Knee Joint Pain Injection Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Knee Joint Pain Injection Import & Export Trends
Table 19. Main Sources of China Knee Joint Pain Injection Import
Table 20. Export Destination of China Knee Joint Pain Injection
Table 21. Global Headquarters and Manufacturing Base of Knee Joint Pain Injection Manufacturers
Table 22. Global Major Manufacturers, Knee Joint Pain Injection Capacity Expansion and Future Plans
Table 23. Global Knee Joint Pain Injection Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)
Table 24. Global Knee Joint Pain Injection Production by Region, 2019-2023, (K Units)
Table 25. Global Knee Joint Pain Injection Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Knee Joint Pain Injection Upstream (Raw Materials)
Table 27. Global Knee Joint Pain Injection Typical Customers
Table 28. Knee Joint Pain Injection Typical Distributors
Table 29. By Type, Global Knee Joint Pain Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 30. By Application, Global Knee Joint Pain Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 31. By Region, Global Knee Joint Pain Injection Market Size, 2019 VS 2023 VS 2030, US$ Million
Table 32. By Region, Global Knee Joint Pain Injection Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Knee Joint Pain Injection Revenue & CAGR,2019 VS 2023 VS 2030, US$ Million
Table 35. By Country, Global Knee Joint Pain Injection Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Knee Joint Pain Injection Revenue Market Share, 2019-2030
Table 37. By Country, Global Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Knee Joint Pain Injection Sales Volume Market Share, 2019-2030
Table 39. Chugai Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 40. Chugai Pharmaceutical Knee Joint Pain Injection Models, Specifications and Application
Table 41. Chugai Pharmaceutical Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 42. Chugai Pharmaceutical Company Profile and Main Business
Table 43. Chugai Pharmaceutical Recent Developments
Table 44. Seikagaku Corporation Company Information, Head Office, Market Area and Industry Position
Table 45. Seikagaku Corporation Knee Joint Pain Injection Models, Specifications and Application
Table 46. Seikagaku Corporation Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 47. Seikagaku Corporation Company Profile and Main Business
Table 48. Seikagaku Corporation Recent Developments
Table 49. Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
Table 50. Teva Pharmaceutical Industries Knee Joint Pain Injection Models, Specifications and Application
Table 51. Teva Pharmaceutical Industries Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 52. Teva Pharmaceutical Industries Company Profile and Main Business
Table 53. Teva Pharmaceutical Industries Recent Developments
Table 54. Zimmer Biomet Holdings Company Information, Head Office, Market Area and Industry Position
Table 55. Zimmer Biomet Holdings Knee Joint Pain Injection Models, Specifications and Application
Table 56. Zimmer Biomet Holdings Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 57. Zimmer Biomet Holdings Company Profile and Main Business
Table 58. Zimmer Biomet Holdings Recent Developments
Table 59. Flexion Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 60. Flexion Therapeutics Knee Joint Pain Injection Models, Specifications and Application
Table 61. Flexion Therapeutics Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 62. Flexion Therapeutics Company Profile and Main Business
Table 63. Flexion Therapeutics Recent Developments
Table 64. Dr. Reddy's Laboratories Company Information, Head Office, Market Area and Industry Position
Table 65. Dr. Reddy's Laboratories Knee Joint Pain Injection Models, Specifications and Application
Table 66. Dr. Reddy's Laboratories Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 67. Dr. Reddy's Laboratories Company Profile and Main Business
Table 68. Dr. Reddy's Laboratories Recent Developments
Table 69. Anika Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 70. Anika Therapeutics Knee Joint Pain Injection Models, Specifications and Application
Table 71. Anika Therapeutics Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 72. Anika Therapeutics Company Profile and Main Business
Table 73. Anika Therapeutics Recent Developments
Table 74. Sanofi S.A Company Information, Head Office, Market Area and Industry Position
Table 75. Sanofi S.A Knee Joint Pain Injection Models, Specifications and Application
Table 76. Sanofi S.A Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 77. Sanofi S.A Company Profile and Main Business
Table 78. Sanofi S.A Recent Developments
Table 79. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 80. Pfizer Knee Joint Pain Injection Models, Specifications and Application
Table 81. Pfizer Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 82. Pfizer Company Profile and Main Business
Table 83. Pfizer Recent Developments
Table 84. Wright Medical Group N.V Company Information, Head Office, Market Area and Industry Position
Table 85. Wright Medical Group N.V Knee Joint Pain Injection Models, Specifications and Application
Table 86. Wright Medical Group N.V Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 87. Wright Medical Group N.V Company Profile and Main Business
Table 88. Wright Medical Group N.V Recent Developments
Table 89. Ferring Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 90. Ferring Pharmaceuticals Knee Joint Pain Injection Models, Specifications and Application
Table 91. Ferring Pharmaceuticals Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 92. Ferring Pharmaceuticals Company Profile and Main Business
Table 93. Ferring Pharmaceuticals Recent Developments
Table 94. Bioventus Company Information, Head Office, Market Area and Industry Position
Table 95. Bioventus Knee Joint Pain Injection Models, Specifications and Application
Table 96. Bioventus Knee Joint Pain Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 97. Bioventus Company Profile and Main Business
Table 98. Bioventus Recent Developments
List of Figure
Figure 1. Knee Joint Pain Injection Picture
Figure 2. By Revenue, Global Knee Joint Pain Injection Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Knee Joint Pain Injection Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Knee Joint Pain Injection Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Knee Joint Pain Injection Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Knee Joint Pain Injection Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Knee Joint Pain Injection Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Knee Joint Pain Injection Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Knee Joint Pain Injection Share of Global Market, 2019-2030
Figure 10. Global Knee Joint Pain Injection Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 11. Global Knee Joint Pain Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023
Figure 12. China Knee Joint Pain Injection Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 13. China Knee Joint Pain Injection Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 14. China Knee Joint Pain Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023
Figure 15. Chinese Local Players, Proportion of Knee Joint Pain Injection Domestic VS Export, 2023
Figure 16. Global Knee Joint Pain Injection Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Knee Joint Pain Injection Capacity Market Share by Region, 2023 VS 2030
Figure 18. Global Knee Joint Pain Injection Production Market Share & Forecast by Region, 2019-2030
Figure 19. Knee Joint Pain Injection Industry Chain
Figure 20. Knee Joint Pain Injection Procurement Model
Figure 21. Knee Joint Pain Injection Sales Model
Figure 22. Knee Joint Pain Injection Sales Channels, Direct Sales and Distribution
Figure 23. Corticosteroid Injections
Figure 24. Hyaluronic Acid Injections
Figure 25. Platelet Rich Plasma Injections
Figure 26. Others
Figure 27. By Type, Global Knee Joint Pain Injection Revenue, 2019-2030, US$ Million
Figure 28. By Type, Global Knee Joint Pain Injection Revenue Market Share, 2019-2030
Figure 29. By Type, Global Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 30. By Type, Global Knee Joint Pain Injection Sales Volume Market Share, 2019-2030
Figure 31. By Type, Global Knee Joint Pain Injection Price, 2019-2030, (US$/Unit)
Figure 32. Hospital
Figure 33. Clinic
Figure 34. Others
Figure 35. By Application, Global Knee Joint Pain Injection Revenue, 2019-2030, US$ Million
Figure 36. By Application, Global Knee Joint Pain Injection Revenue Market Share, 2019-2030
Figure 37. By Application, Global Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 38. By Application, Global Knee Joint Pain Injection Sales Volume Market Share, 2019-2030
Figure 39. By Application, Global Knee Joint Pain Injection Price, 2019-2030, (US$/Unit)
Figure 40. By Region, Global Knee Joint Pain Injection Revenue Market Share, 2019-2030
Figure 41. By Region, Global Knee Joint Pain Injection Sales Volume Market Share, 2019-2030
Figure 42. North America Knee Joint Pain Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, North America Knee Joint Pain Injection Revenue Market Share, 2023
Figure 44. Europe Knee Joint Pain Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, Europe Knee Joint Pain Injection Revenue Market Share, 2023
Figure 46. Asia Pacific Knee Joint Pain Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country/Region, Asia Pacific Knee Joint Pain Injection Revenue Market Share, 2023
Figure 48. South America Knee Joint Pain Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. By Country, South America Knee Joint Pain Injection Revenue Market Share, 2023
Figure 50. Middle East & Africa Knee Joint Pain Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 51. U.S. Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 52. By Company, U.S. Knee Joint Pain Injection Market Share, 2023
Figure 53. By Type, U.S. Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 54. By Application, U.S. Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 55. Europe Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 56. By Company, Europe Knee Joint Pain Injection Market Share, 2023
Figure 57. By Type, Europe Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 58. By Application, Europe Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 59. China Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 60. By Company, China Knee Joint Pain Injection Market Share, 2023
Figure 61. By Type, China Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 62. By Application, China Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 63. Japan Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 64. By Company, Japan Knee Joint Pain Injection Market Share, 2023
Figure 65. By Type, Japan Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 66. By Application, Japan Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 67. South Korea Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 68. By Company, South Korea Knee Joint Pain Injection Market Share, 2023
Figure 69. By Type, South Korea Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 70. By Application, South Korea Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 71. Southeast Asia Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 72. By Company, Southeast Asia Knee Joint Pain Injection Market Share, 2023
Figure 73. By Type, Southeast Asia Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 74. By Application, Southeast Asia Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 75. India Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 76. By Company, India Knee Joint Pain Injection Market Share, 2023
Figure 77. By Type, India Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 78. By Application, India Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 79. Middle East & Asia Knee Joint Pain Injection Sales Volume, 2019-2030, (K Units)
Figure 80. By Company, Middle East & Asia Knee Joint Pain Injection Market Share, 2023
Figure 81. By Type, Middle East & Asia Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 82. By Application, Middle East & Asia Knee Joint Pain Injection Sales Volume Market Share, 2023 VS 2030
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|